RESUMEN
To investigate the protective effects of ginkgo diterpene lactone meglumine injection (GDLMI) on cerebral focal ischemia reperfusion injury induced by middle cerebral artery occlusion (MCAO) in rats, and explore its possible mechanism. One hundred and forty male SD rats were randomly divided into sham operation group, model group, ginkgo biloba extract injection (Ginaton, 1.0 mLâ¢kg⻹) group, nimodipine (0.4 mgâ¢kg⻹) group, and GDLMI (5.2, 2.6, 1.3 mgâ¢kg⻹) groups; All of rats received corresponding drugs by tail vein injection 4 days before operation (normal saline in model group and sham operation group). Except the sham operation group, the cerebral ischemic stroke model was established by MCAO method in right brain of the other rats. After 3 h of ischemia, all the animals received intravenous administration again. The neurobehavioral scores of rats after ischemia-reperfusion were evaluated and the infarct rate of brain tissue was observed by TTC staining. The super oxide dismutase (SOD), glutathione (GSH), malondialdehyde (MDA) and lactic acid (LA) contents in brain tissue homogenate and the concentration of Ca2+, glutamate (Glu) and aspartate (Asp), creatine phosphate kinase (CK-BB) and lactate dehydrogenase (LDH) content changes in cerebrospinal fluid were measured. As compared with the sham operation group, the cerebral infarction rate was increased significantly in the model group; the content of MDA and LA in the homogenate of brain tissue was increased, and the content of GSH and SOD was decreased; in cerebrospinal fluid, Ca2+ concentration was decreased, and the content of Glu and Asp, CK-BB and LDH increased significantly. As compared with the model group, the high and medium dose GDLMI groups can significantly reduce the cerebral infarction rate and improve the symptoms of neurological impairment; increase SOD and GSH activity, reduce MDA and LA content in serum; increase Ca2+ concentration in cerebrospinal fluid and decrease the content of neurotransmitter Glu and Asp as well as CK-BB and LDH. GDLMI could obviously improve neurologic impairment in model rats, and the mechanism may be related to recovering the blood brain barrier, scavenging free radicals, decreasing free Ca2+ inflow into the cells and the content of excitatory amino acid in cerebrospinal fluid to improve its protective effect on cerebral ischemia.
Asunto(s)
Isquemia Encefálica/tratamiento farmacológico , Ginkgo biloba/química , Lactonas/farmacología , Daño por Reperfusión/tratamiento farmacológico , Terpenos/farmacología , Animales , Ácido Aspártico/líquido cefalorraquídeo , Calcio/líquido cefalorraquídeo , Forma BB de la Creatina-Quinasa/líquido cefalorraquídeo , Ácido Glutámico/líquido cefalorraquídeo , Glutatión/análisis , L-Lactato Deshidrogenasa/líquido cefalorraquídeo , Ácido Láctico/análisis , Masculino , Malondialdehído/análisis , Meglumina , Ratas , Ratas Sprague-Dawley , Superóxido Dismutasa/análisisRESUMEN
The cause of preeclampsia remains unknown and calcium and magnesium supplement are being suggested as means of prevention. The objective of this study was to assess magnesium and calcium in the plasma and cerebrospinal fluid of Nigerian women with preeclampsia and eclampsia. Setting was University of Benin Teaching Hospital, in Nigeria. It was a cross-sectional study comprising of eleven patients and twenty-three controls. The mean, standard deviation and Standard Error of Mean (SEM) were calculated. Student 't' test method was applied. Plasma calcium was significantly lower in patients than controls (9.2 +/- 1.02 Vs 9.98 +/- 0.87mg/dl, P 0.043) "t" test. The CSF calcium and magnesium levels were lower in patients than controls, (5.66 +/- 1.22 vs 6.67 +/- 1.15 mg/ dl, P 0.043 and 1.75 +/- 0.56 vs 1.91 +/- 0.19 mg/dl, P 0. < 0.0001) respectively. There is extracellular calcium and magnesium reduction in patients with preeclampsia and eclampsia. This reduction may have a cause and effect relationship with these disorders.
Asunto(s)
Calcio/sangre , Eclampsia/etiología , Magnesio/sangre , Preeclampsia/etiología , Adolescente , Adulto , Calcio/líquido cefalorraquídeo , Estudios de Casos y Controles , Cesárea , Estudios Transversales , Eclampsia/sangre , Eclampsia/prevención & control , Espacio Extracelular , Femenino , Humanos , Magnesio/líquido cefalorraquídeo , Persona de Mediana Edad , Nigeria , Preeclampsia/sangre , Preeclampsia/prevención & control , Embarazo , Tercer Trimestre del Embarazo , Adulto JovenRESUMEN
Eight multiparous, nonlactating pregnant Holstein cows (at 198 +/- 35 days of gestation and weighing 608 + 24 kg) and seven nonlactating nonpregnant ovariectomized heifers (weighing 370 + 29 kg) were confined to wooden metabolism crates in an electric and magnetic field chamber. Subarachnoidal catheters were inserted before the activation of the electric and magnetic fields. For 30 days, cows and heifers were continuously exposed in separate trials to electric and magnetic fields (60 Hz, 10 kV/m, and 30 microT). Blood plasma and cerebrospinal fluid samples were collected for 3 consecutive days before the exposure period, the last 3 days of the exposure period, and for 3 days starting 5 days after the exposure period. Concentrations of Ca, Mg, Cu, Zn, Fe, Mn, Na, P, and K in blood plasma and cerebrospinal fluid were determined. Exposure to electric and magnetic fields resulted in decreased concentrations of Mg in blood plasma and in increased concentrations of Ca and P and decreased concentrations of Fe and Mn in cerebrospinal fluid.
Asunto(s)
Bovinos/sangre , Bovinos/líquido cefalorraquídeo , Campos Electromagnéticos/efectos adversos , Oligoelementos/sangre , Oligoelementos/líquido cefalorraquídeo , Animales , Calcio/sangre , Calcio/líquido cefalorraquídeo , Femenino , Hierro/sangre , Hierro/líquido cefalorraquídeo , Magnesio/sangre , Magnesio/líquido cefalorraquídeo , Manganeso/sangre , Manganeso/líquido cefalorraquídeo , Fósforo/sangre , Fósforo/líquido cefalorraquídeo , EmbarazoRESUMEN
Cerebrospinal fluid (CSF) collected at the atlanto-occipital site and serum were obtained from 10 male, 8-week-old, Holstein calves after sedation with xylazine hydrochloride. Glucose, creatine kinase, alkaline phosphatase, urea nitrogen, creatinine, sodium, potassium, chloride, calcium, phosphorus, total protein, and albumin were determined in serum and CSF. Optical characteristics, specific gravity, total red blood cell and nucleated cell counts and differentials were also evaluated in the CSF. Additionally, CSF protein electrophoresis and immunoglobulin concentrations were determined. Then, albumin quotients (AQ) were derived. Erythrocytes were observed in 9 of 10 CSF samples. Total nucleated cell counts ranged from 0-10 cells x 10(6)/L with a mean of 3 cells x 10(6)/L. Differential nucleated cell count in the CSF consisted primarily of lymphocytes/small mononuclear cells (57%), fewer monocytes/ large mononuclear cells (38%), and scant neutrophils (4%) and eosinophils (0.05%). The concentration of sodium (134 to 139 mEq/L) was similar to that of serum, but the concentration of potassium (2.8 to 3 mEq/L) was lower than that of serum. Creatine kinase activity (0 to 4 U/L) of CSF was markedly lower than serum activity. The CSF glucose concentration was approximately 80% of the serum value. Cerebrospinal fluid total protein concentration determined by electrophoresis ranged from 110 to 330 mg/L with a mean of 159 mg/L. Cerebrospinal fluid albumin ranged from 48 to 209 mg/L with a mean of 86 mg/L. In all CSF samples, radial immunodiffusion of unaltered CSF and concentrated CSF (four-fold concentration) revealed quantities undetectable by the present techniques in which the lowest standard values for IgG1, IgG, and IgM determinations was 70 mg/L and IgG2 was 30 mg/L. The albumin quotient ranged from 0.15 to 0.65 with a mean of 0.25. Based on the results of this study, CSF may be collected at the atlanto-occipital site safely and efficiently in calves, and reported values for CSF from adult cattle may not be suitable for evaluation of CSF collected from immature cattle.
Asunto(s)
Anestésicos/farmacología , Bovinos/líquido cefalorraquídeo , Líquido Cefalorraquídeo/química , Xilazina/farmacología , Fosfatasa Alcalina/líquido cefalorraquídeo , Anestésicos/administración & dosificación , Animales , Articulación Atlantooccipital , Calcio/líquido cefalorraquídeo , Bovinos/fisiología , Líquido Cefalorraquídeo/citología , Creatina Quinasa/líquido cefalorraquídeo , Creatinina/líquido cefalorraquídeo , Eritrocitos/citología , Glucosa/líquido cefalorraquídeo , Inmunoglobulina G/líquido cefalorraquídeo , Inmunoglobulina M/líquido cefalorraquídeo , Inyecciones Subcutáneas/veterinaria , Linfocitos/citología , Masculino , Neutrófilos/citología , Nitrógeno/líquido cefalorraquídeo , Fósforo/líquido cefalorraquídeo , Sodio/líquido cefalorraquídeo , Gravedad Específica , Xilazina/administración & dosificaciónRESUMEN
The effect of dietary calcium (Ca) supplementation on blood pressure (BP) and the central nervous system (CNS) mechanism underlying this effect were studied in angiotensin II (Ang II)-induced hypertensive rats. The effects of dietary Ca (0.5, 2, 4%) on systolic blood pressure (SBP), ionized Ca concentration (Ca++) in cerebrospinal fluid (CSF) and central norepinephrine (NE) turnover were investigated in male Wistar rats receiving subcutaneous infusion of Ang II (100 ng/min). Central NE turnover was studied by measuring 3-methoxy-4-hydroxyphenylglycol (MHPG) concentration in CSF with multiple electrode liquid chromatography. Ang II significantly increased SBP, and dietary Ca dose-dependently attenuated the increase. SBP inversely correlated with Ca++ and MHPG in CSF. Intracerebroventricular injection of CaCl2 more markedly reduced BP in Ang II-treated rats than that in control rats. These results suggest that modulation of central NE turnover possibly caused by the increase in CNS Ca++ is involved in the anti-hypertensive mechanism of dietary Ca supplementation in Ang II-induced hypertensive rats.
Asunto(s)
Angiotensina II/antagonistas & inhibidores , Calcio de la Dieta/administración & dosificación , Sistema Nervioso Central/fisiopatología , Hipertensión/prevención & control , Angiotensina II/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Calcio/sangre , Calcio/líquido cefalorraquídeo , Sistema Nervioso Central/efectos de los fármacos , Diuresis/efectos de los fármacos , Frecuencia Cardíaca/efectos de los fármacos , Hipertensión/etiología , Hipertensión/fisiopatología , Masculino , Metoxihidroxifenilglicol/líquido cefalorraquídeo , Natriuresis/efectos de los fármacos , Norepinefrina/metabolismo , Ratas , Ratas WistarRESUMEN
Few synaptic transmitters are known to exist that are not represented in some region or another, or at some layer or other, in the cerebral cortex of mammalian brain. The more difficult job than mere identification of which substances are present, is that of the assignment of particular functional role(s) of such substances, and as well, of determining upon exactly which element(s) of the known synaptic circuitry of neocortex, such transmitters operate. Current wisdom subscribes to the view that the excitatory amino acids, most likely L-glutamate, and L-aspartate but perhaps also L-cysteate, L-homocysteate, L-cysteine sulfinate or even (although much less likely) the endogenous dipeptide substance, N-acetyl-L-aspartyl-L-glutamate, are the major excitatory synaptic transmitters of intracortical (associational) fibres, of corticofugal projections, and, as this article will attest, of thalamocortical inputs, as well. What particular limits, or restrictions, are imposed upon these generalizations, such as whether the data pertain only to primary sensory areas or follow some other yet to be determined rule, remains to be discovered in future experiments. This paper first presents an overview of the advances in understanding that have come about during the past few decades concerning the synaptic roles of amino acid transmitters. Next, an experimental section presents new evidence based on release studies and the microiontophoretic approach, which supports the view that the amino acids, glutamate and aspartate, interact with specific, pharmacologically identified subtypes of receptors in neocortex as transmitters of synaptic excitation released from thalamic afferent terminals.
Asunto(s)
Aminoácidos/fisiología , Corteza Cerebral/fisiología , Neuronas Aferentes/fisiología , Neurotransmisores/fisiología , Sinapsis/fisiología , 2-Amino-5-fosfonovalerato/farmacología , Aminoácidos/metabolismo , Animales , Calcio/líquido cefalorraquídeo , Gatos , Corteza Cerebral/citología , Cromatografía Líquida de Alta Presión , Estimulación Eléctrica , Electrodos , Femenino , Iontoforesis , Ácido Quinurénico/farmacología , Magnesio/líquido cefalorraquídeo , Masculino , Vías Nerviosas/citología , Vías Nerviosas/fisiología , Quinoxalinas/farmacología , Corteza Somatosensorial/citología , Corteza Somatosensorial/fisiología , Tálamo/citología , Tálamo/fisiologíaRESUMEN
Marked differences in CSF levels of both calcium and phosphorus were observed in patients with dementia and aged controls when compared with adult controls. A significant decrease in both Ca and P in CSF was observed in Alzheimer's type dementia (p less than 0.01) and multi-infarct dementia cases (p less than 0.01). The geriatric controls also showed a significant decrease in both Ca and P. A 60% decrease in diffusible Ca in CSF was noted both in patients and geriatric controls when compared to adult controls (p less than 0.001). Diffusible P was also decreased in all three groups (p less than 0.05). A marginal decrease in serum Ca and slight increase in P was observed in both patients and geriatric controls. The significant decrease in CSF Ca and P in both groups of patients compared with aged controls suggests this lowering of Ca and P is not due to solely to the aging process and indicates a role in the pathology of age-related disorders.
Asunto(s)
Calcio/sangre , Calcio/líquido cefalorraquídeo , Demencia/sangre , Demencia/líquido cefalorraquídeo , Fósforo/sangre , Fósforo/líquido cefalorraquídeo , Adulto , Anciano , Enfermedad de Alzheimer/sangre , Enfermedad de Alzheimer/líquido cefalorraquídeo , Enfermedad de Alzheimer/psicología , Demencia/psicología , Demencia por Múltiples Infartos/sangre , Demencia por Múltiples Infartos/líquido cefalorraquídeo , Demencia por Múltiples Infartos/psicología , Femenino , Humanos , India , Masculino , Persona de Mediana Edad , Escalas de Valoración PsiquiátricaRESUMEN
The contents of indispensable major elements sodium (Na), phosphorus (P), calcium (Ca), magnesium (Mg), trace elements iron (Fe), copper (Cu), nickel (Ni), zinc (Zn), strontium (Sr), vanadium (V), chromium (Cr), manganese (Mn), molybdenum (Mo), and other elements lead (Pb), silicon (Si), aluminium (Al), titanium (Ti), barium (Ba), lanthanum (La), cadmium (Yb), cerium (Ce), scandium (Sc), silver (Ag), in cerebrospinal fluid (CSF) were measured in 13 patients suffering from Parkinson disease before and after autotransplantation of adrenal medulla. It was found that while the patients' objective symptoms were relieved and the contents of monoamine transmitters were changed, the contents of P, V, Co, Cr, in CSF increased significantly (P less than 0.05 or 0.01) at the first, 2nd, 4th, 6th, and 8th week, the contents of Mn in CSF also increased significantly at the first 4th week (P less than 0.05) but decreased significantly at the 8th week the contents of Zn in CSF increased significantly (P less than 0.05) at the 2nd week; Mo increased significantly (P less than 0.05 or 0.01) at the 4th and 8th week B increased significantly (P less than 0.05) at the first week; the contents of Ca, Na, Sr, Ba, Al, Ti, La, Ce, Yb, Sc, Ag in CSF increased significantly (P less than 0.05 or 0.01) at the 8th week, Mg, Fe, Cu Ni, Pb, Si, Cd remained unchanged after operation. The results suggest that the contents of these chemical elements can be affected by this kind of operation, indicating that these elements are involved in the pathogenesis of Parkinsonism.
Asunto(s)
Médula Suprarrenal/trasplante , Encéfalo/cirugía , Enfermedad de Parkinson/cirugía , Oligoelementos/líquido cefalorraquídeo , Calcio/líquido cefalorraquídeo , Humanos , Enfermedad de Parkinson/líquido cefalorraquídeo , Fósforo/líquido cefalorraquídeo , Sodio/líquido cefalorraquídeoRESUMEN
Mineral metabolism in the cerebrospinal fluid (CSF) of children is poorly understood. Recent reports have suggested a neuroregulatory role for calcitonin. We examined the hypotheses that in children (1) CSF levels of calcium and phosphorus might be low, (2) CSF levels of magnesium might be higher than serum levels of magnesium, and (3) immunoreactive calcitonin might be present in the CSF. We examined serum and CSF samples of 45 children, aged 8 days to 16 years, undergoing spinal taps for suspected meningitis or as part of leukemia therapy. Both serum and CSF levels of calcium correlated with those of magnesium. There was no correlation for CSF levels vs serum levels of calcium, magnesium, or phosphorus. The CSF levels of calcium and phosphorus were lower than the serum levels of these elements, but the CSF levels of magnesium were higher than the serum levels of magnesium. Calcitonin was detected in the CSF of 8% of samples assayed (range, 14 to 175 ng/L [14 to 175 pg/mL]). Two of these five samples had bacteriologically proven meningitis, and two samples were from patients less than 2 months of age. The CSF levels of calcitonin did not correlate with the serum levels of calcitonin. Thus, in children CSF levels of calcium and phosphorus are low, CSF levels of magnesium are higher than the serum levels, and the level of immunoreactive calcitonin is usually not present in the CSF but possibly is elevated in meningitis and early infancy.
Asunto(s)
Calcitonina/líquido cefalorraquídeo , Calcio/líquido cefalorraquídeo , Magnesio/líquido cefalorraquídeo , Fósforo/líquido cefalorraquídeo , Adolescente , Calcitonina/sangre , Calcio/sangre , Enfermedades del Sistema Nervioso Central/sangre , Enfermedades del Sistema Nervioso Central/líquido cefalorraquídeo , Niño , Preescolar , Humanos , Lactante , Recién Nacido , Magnesio/sangre , Fósforo/sangreRESUMEN
The present study was designed to determine whether acute expansion of the extracellular fluid volume influenced the digitalis-like activity of human cerebrospinal fluid (CSF), previously described by our laboratory. Human CSF samples, drawn before and 30 minutes after the intravenous infusion of 1 liter of either saline or glucose solutions, were assayed for digitalis-like activity by inhibition of either the 86Rb+ uptake into human erythrocytes or by the activity of a purified Na+ - K+ ATPase. The CSF inhibitory activity on both systems significantly increased after the infusion of sodium solutions but did not change after the infusion of glucose. These results indicate that the digitalis-like factor of human CSF might be involved in the regulation of the extracellular fluid volume and electrolyte content and thereby in some of the physiological responses to sodium loading.
Asunto(s)
Líquido Cefalorraquídeo/fisiología , Digitalis , Espacio Extracelular/fisiología , Plantas Medicinales , Plantas Tóxicas , Calcio/líquido cefalorraquídeo , Eritrocitos/metabolismo , Femenino , Glucosa/farmacología , Humanos , Cinética , Masculino , Potasio/líquido cefalorraquídeo , Rubidio/sangre , Sodio/líquido cefalorraquídeo , Cloruro de Sodio/farmacología , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidoresRESUMEN
Time and temperature effects on postmortem cerebrospinal fluid samples from 60 adult mongrel dogs were studied. After death the dogs were held at 4, 20, or 37 degrees C for intervals of 3, 6, 12, 24, or 48 h. Antemortem and postmortem cerebrospinal fluid was evaluated for sodium, chloride, potassium, urea nitrogen, glucose, creatinine, calcium, phosphorus, and carbon dioxide. Sodium and urea nitrogen values remained stable. Chloride may be of forensic science value. Low levels of postmortem calcium might indicate antemortem hypocalcemia; high levels of postmortem glucose may indicate antemortem hyperglycemia. Calcium and creatinine levels increased slightly but continually after death; carbon dioxide values dropped.
Asunto(s)
Líquido Cefalorraquídeo/análisis , Cambios Post Mortem , Animales , Calcio/líquido cefalorraquídeo , Dióxido de Carbono/líquido cefalorraquídeo , Cloruros/líquido cefalorraquídeo , Creatinina/líquido cefalorraquídeo , Perros , Glucosa/líquido cefalorraquídeo , Fósforo/líquido cefalorraquídeo , Potasio/líquido cefalorraquídeo , Sodio/líquido cefalorraquídeo , Temperatura , Factores de Tiempo , Urea/líquido cefalorraquídeoAsunto(s)
Barrera Hematoencefálica , Calcio/líquido cefalorraquídeo , Fósforo/líquido cefalorraquídeo , Animales , Calcio/sangre , Citratos/líquido cefalorraquídeo , Perros , Humanos , Hipercalcemia/líquido cefalorraquídeo , Lactatos/líquido cefalorraquídeo , Glándulas Paratiroides/cirugía , Hormona Paratiroidea/farmacología , Fosfatos/farmacología , Fósforo/sangre , Uremia/líquido cefalorraquídeoRESUMEN
In severely depressed patients with primary affective illness, consistent decreases in total calcium concentration have been demostrated in both CSF and serum following successful ECT treatment. The hypocalcemia does not appear to occur after the initial ECTs, but develops after three to five treatments, coincident with an acceleration in clinical antidepressant effects, and is not an artifact of the anesthetic premedications or mechanical ventilation of the patients. Evidence linking alterations in calcium metabolism to mood is reviewed and a number of mechanisms by which the calcium change might result from ECT and mediated its effects on mood are discussed.
Asunto(s)
Calcio/metabolismo , Depresión/terapia , Terapia Electroconvulsiva , Adulto , Anciano , Calcitonina/fisiología , Calcio/sangre , Calcio/líquido cefalorraquídeo , Depresión/metabolismo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Hormona Paratiroidea/fisiología , Fósforo/sangre , Escalas de Valoración Psiquiátrica , Factores de Tiempo , Triptaminas/metabolismoAsunto(s)
Calcio/líquido cefalorraquídeo , Ácido Edético/farmacología , Sed/efectos de los fármacos , Animales , Temperatura Corporal , Calcio/farmacología , Perros , Ácido Edético/líquido cefalorraquídeo , Hipotálamo/efectos de los fármacos , Hipotálamo/fisiología , Concentración Osmolar , Factores de TiempoAsunto(s)
Electrólitos/metabolismo , Circulación Extracorporea , Animales , Arterias , Sangre , Calcio/sangre , Calcio/líquido cefalorraquídeo , Dióxido de Carbono/sangre , Líquido Cefalorraquídeo , Perros , Recuento de Eritrocitos , Concentración de Iones de Hidrógeno , Oxígeno/sangre , Presión Parcial , Fósforo/sangre , Fósforo/líquido cefalorraquídeo , Potasio/sangre , Potasio/líquido cefalorraquídeo , VenasRESUMEN
Studies were carried out to evaluate the changes in content of calcium and magnesium in brain during acute uremia in dogs. Ca content in gray and white matter of brain increased significantly after 3 days of acute uremia and this increment was prevented by thyroparathyroidectomy (TPTX). The administration of parathyroid extract (PTE) to normal dogs and TPTX uremic animals produced a significant rise in brain Ca. These changes were not related to alteration in the concentration of Ca in plasma or cerebrospinal fluid, to changes in calcium-phosphorus product, or to changes in blood pH. Furthermore, the infusion of large amounts of phosphate to vitamin D2-treated animals with suppressed parathyroid gland activity produced marked elevation in calcium-phosphorus product but no significant change in brain Ca. Also, uremia in vitamin D2-treated TPTX dogs failed to increase calcium content in brain despite marked elevation in calcium-phosphorus product. Hemodialysis significantly reduced Ca content of brain but the values were still significantly higher than normal. Mg content increased modestly only in the white matter of uremic dogs with intact parathyroid glands and in normal dogs and TPTX uremic dogs receiving PTE. The results indicate that (a) acute uremia of 3 days is associated with a marked rise of Ca content of brain and modest increment of Mg in certain parts of the brain, and (b) these alterations are not related to uremia, per se, but are dependent on the presence of excess parathyroid hormone. It is suggested that the neurological abnormalities noted in acute uremia may be related in part to the rise in the Ca content of brain.